v3.25.2
Condensed Statements of Stockholders' Equity - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Total
Balance, Beginning at Dec. 31, 2023 $ 7 $ 563,487 $ 99 $ (244,763) $ 318,830
Balance, Beginning (in shares) at Dec. 31, 2023 70,453,342        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock, net of offering costs $ 2 238,797     238,799
Issuance of common stock, net of offering costs (in shares) 22,450,206        
Exercise of stock options   1,926     1,926
Exercise of stock options (shares) 380,980        
Stock-based compensation   4,871     4,871
Other comprehensive loss     (960)   (960)
Net loss       (28,525) (28,525)
Balance, Ending at Mar. 31, 2024 $ 9 809,081 (861) (273,288) 534,941
Balance, Ending (in shares) at Mar. 31, 2024 93,284,528        
Balance, Beginning at Dec. 31, 2023 $ 7 563,487 99 (244,763) 318,830
Balance, Beginning (in shares) at Dec. 31, 2023 70,453,342        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss         (60,022)
Balance, Ending at Jun. 30, 2024 $ 9 816,304 (1,054) (304,785) 510,474
Balance, Ending (in shares) at Jun. 30, 2024 93,643,341        
Balance, Beginning at Mar. 31, 2024 $ 9 809,081 (861) (273,288) 534,941
Balance, Beginning (in shares) at Mar. 31, 2024 93,284,528        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options and vesting of restricted stock units   1,577     1,577
Exercise of stock options and vesting of restricted stock units (in shares) 283,039        
Purchase of common stock under Employee Stock Purchase Plan   422     422
Purchase of common stock under Employee Stock Purchase Plan (in shares) 75,774        
Stock-based compensation   5,224     5,224
Other comprehensive loss     (193)   (193)
Net loss       (31,497) (31,497)
Balance, Ending at Jun. 30, 2024 $ 9 816,304 (1,054) (304,785) 510,474
Balance, Ending (in shares) at Jun. 30, 2024 93,643,341        
Balance, Beginning at Dec. 31, 2024 $ 9 837,363 420 (378,576) $ 459,216
Balance, Beginning (in shares) at Dec. 31, 2024 94,838,466       94,838,466
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options   2,261     $ 2,261
Exercise of stock options (shares) 367,217        
Stock-based compensation   9,059     9,059
Other comprehensive loss     (19)   (19)
Net loss       (40,798) (40,798)
Balance, Ending at Mar. 31, 2025 $ 9 848,683 401 (419,374) 429,719
Balance, Ending (in shares) at Mar. 31, 2025 95,205,683        
Balance, Beginning at Dec. 31, 2024 $ 9 837,363 420 (378,576) $ 459,216
Balance, Beginning (in shares) at Dec. 31, 2024 94,838,466       94,838,466
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss         $ (76,913)
Balance, Ending at Jun. 30, 2025 $ 10 1,044,346 204 (455,489) $ 589,071
Balance, Ending (in shares) at Jun. 30, 2025 105,341,296       105,341,296
Balance, Beginning at Mar. 31, 2025 $ 9 848,683 401 (419,374) $ 429,719
Balance, Beginning (in shares) at Mar. 31, 2025 95,205,683        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock, net of offering costs $ 1 187,100     187,101
Issuance of common stock, net of offering costs (in shares) 9,935,419        
Exercise of stock options and vesting of restricted stock units   233     233
Exercise of stock options and vesting of restricted stock units (in shares) 151,535        
Purchase of common stock under Employee Stock Purchase Plan   597     597
Purchase of common stock under Employee Stock Purchase Plan (in shares) 48,659        
Stock-based compensation   7,733     7,733
Other comprehensive loss     (197)   (197)
Net loss       (36,115) (36,115)
Balance, Ending at Jun. 30, 2025 $ 10 $ 1,044,346 $ 204 $ (455,489) $ 589,071
Balance, Ending (in shares) at Jun. 30, 2025 105,341,296       105,341,296